ATG7 deficiency promote apoptotic death induced by Cisplatin in human esophageal squamous cell carcinoma cells - 23/03/15
Abstract |
Cisplatin-(DDP)-based adjuvant chemotherapy is widely used for the treatment of esophageal cancer. However, DDP-based combinatorial treatments can eventually result in tumor resistance response. Therefore, new therapeutic strategies and/or new adjuvant drugs still need to be explored. In this study, we aimed to understand the role of autophagy in ESCC cells resistance to Cisplatin and discuss its potential therapeutic implication. We found that exposure to Cisplatin induced a significant increase in LC3 formation. While the proliferation of ESCC cells was inhibited upon Cisplatin exposure, inhibition of autophagy by ATG7 interference further increased the sensitivity to chemotherapy. Meanwhile, the Cisplatin-induced apoptotic cell death was significantly enhanced. These results suggest that autophagy may function importantly in ESCC cells resistance to Cisplatin. Intriguingly, the resistance could be recovered by autophagy inhibition. This also points to potential therapy for ESCC by perturbing autophagy.
Le texte complet de cet article est disponible en PDF.Key words : esophageal squamous cell carcinoma, Cisplatin, ATG7, autophagy, apoptosis
Plan
Vol 100 - N° 7-8
P. E15-E21 - juillet 2013 Retour au numéro
Article précédent
- Cancer médullaire de la thyroïde (CMT) de l'enfant
- Amandine Berdelou, Dana Hartl, Abir Al Ghuzlan, Haïtham Mirghani, Cécile Chougnet, Éric Baudin, Martin Schlumberger, Sophie Leboulleux
- Prognostic factors of young women (? 35 years) with node positive breast cancer: possible influence on post-therapeutic follow-up
- Thomas Filleron, Florence Dalenc, Andrew Kramar, Marc Spielmann, Christelle Levy, Pierre Fumoleau, Jean-Luc Canon, Anne-Laure Martin, Henri Roché
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?